Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Economic Burden of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients with Commercial Insurance in the United States

Naomi Sacks, PhD, Bridget Healey, MPH, Philip Cyr, MPH, Katharine Batt, MD MSc, Noreen Roth Henig, MD

Blood (2019) 134 (Supplement_1): 3410.

https://doi.org/10.1182/blood-2019-127197

Published: 2019

Journal Articles

Prevalence of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in the USA, Europe and Japan

Emilie Hofstetter, MBA, Noreen Roth Henig, MD, Dominik Kappeler, MD

Blood (2019) 134 (Supplement_1): 5678.

https://doi.org/10.1182/blood-2019-128226

Published: 2019

Journal Articles

Ruxolitinib and Steroid Refractory/Dependent Bronchiolitis Obliterans after Hematopoietic Cell Transplantation: A Steroid Sparing Agent That Also Resulted in Improved Lung Function in Children

Michelle Schoettler, MD, Meera Subramaniam, MD, Steven P. Margossian, MD PhD

Blood (2018) 132 (Supplement 1): 3407.

https://doi.org/10.1182/blood-2018-99-114971

Published: 2018

Journal Articles

Successful Salvage of Refractory Burkitts Lymphoma Using Maximum Intensity of the DA EPOCH-R Regimen—a Case Report

Andrew K. McMillan, FRCP, Sarah Hartley, MBBS, MRCP, Catherine Loughran, Mark Bishton, Eleanor James, Catherine Griffiths, Faith Richardson, Christopher P Fox, MBChB PhD

Blood (2017) 130 (Supplement 1): 5229.

https://doi.org/10.1182/blood.V130.Suppl_1.5229.5229

Published: 2017

Journal Articles

Pre-Transplant Pulmonary Function Test Parameters of FEF50% (Forced expiratory flow at 50% of forced vital capacity) and RV (residual volume) in Combination Can Predict the Risk for Development of Lung Gvhd after Allogeneic Transplantation

Wilson Lam, MD, Arjun Datt Law, MBBS, MD DM, Fotios V. Michelis, MD PhD, Santhosh Thyagu, MD, Auro Viswabandya, MDMDcine,DM Clinical Hematology, Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD PhD, Theodore Marras, MD MSc, Shikha Mittoo, MD MHS, Dennis Kim, MD

Blood (2017) 130 (Supplement 1): 1973.

https://doi.org/10.1182/blood.V130.Suppl_1.1973.1973

Published: 2017

Journal Articles

Comparison of Impulse Oscillometry with Spirometry to Assess Lung Function in Children with Sickle Cell Disease (SCD)

Nnenna R Ukachi, MBBS, Elizabeth K Fiorino, MD, Martin Lesser, PhD, Karalyn Pappas, Abena Appiah-Kubi, MD MPH, Donna Brower, MSN, CPNP, Maria Teresa Santiago, MD, Banu Aygun, MD

Blood (2017) 130 (Supplement 1): 2247.

https://doi.org/10.1182/blood.V130.Suppl_1.2247.2247

Published: 2017

Journal Articles

How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation

Alpana Waghmare, Janet A. Englund, Michael Boeckh

Blood (2016) 127 (22): 2682–2692.

https://doi.org/10.1182/blood-2016-01-634873

Published: 2016

Includes: Supplemental data

Journal Articles

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Ifigeneia Tzannou, MD, Bilal Omer, MD, Anastasia Papadopoulou, PhD, Ulrike Gerdemann, MD, Colton Smith, PhD, Adrian P. Gee, PhD, Bambi J Grilley, Malcolm K. Brenner, MB, PhD FRCP, FRCPath, Catherine M. Bollard, MD, Ann M. Leen, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD

Blood (2015) 126 (23): 1926.

https://doi.org/10.1182/blood.V126.23.1926.1926

Published: 2015

Journal Articles

Clinical Features, Outcomes and Prognosis of Oropharyngeal Lymphoma: An Analysis from the Thai Lymphoma Study Group (TLSG)

Blood (2015) 126 (23): 5088.

https://doi.org/10.1182/blood.V126.23.5088.5088

Published: 2015

Journal Articles

The V50/V25 Ratio, a Marker of Small Airway Disease, Is Highly Predictive of Survival after Allogeneic Hematopoietic Cell Transplantation

Mika Nakamae, MD, PhD, Hirohisa Nakamae, Mariko Yamashita, Mitsutaka Nishimoto, MD, PhD, Yoshiki Hayashi, MD, PhD, Hideo Koh, MD, PhD, Takahiko Nakane, MD, PhD, Yasuhiro Nakashima, MD, PhD, Asao Hirose, MD, PhD, Masayuki Hino, MD, PhD

Blood (2014) 124 (21): 1208.

https://doi.org/10.1182/blood.V124.21.1208.1208

Published: 2014

Journal Articles

Screening With Spirometry Is A Useful Predictor Of Later Development Of Non-Infectious Pulmonary Syndromes In Patients Undergoing Allogeneic Stem Cell Transplantation

Thompson A Philip, MBBS, FRACP, FRCPA, Andrew B M Lim, MBBS, FRACP, FRCPA, Mark Tacey, Ramzi Hijazi, MBBS, Ashley P. Ng, MBBS, BMedSc, PhD, FRACP, FRCPA, Jeffrey Szer, BMedSc, MBBS, FRACP, David Ritchie, MBBS, PhD, FRACP, FRCPA, Ashish R. Bajel, MBBS, FRACP, FRCPA

Blood (2013) 122 (21): 4603.

https://doi.org/10.1182/blood.V122.21.4603.4603

Published: 2013

Journal Articles

Low Dose Busulfan Is Associated with Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation.

Lee Gazourian, MD, Angela J Rogers, MD, MPH, Ruby Igbanga, Gerald L Weinhouse, MD, Robert J Soiffer, MD, Joseph H Antin, MD, Jerome Ritz, MD, Vincent T Ho, MD, George R Washko, MD, Rebecca M Baron, MD

Blood (2012) 120 (21): 3128.

https://doi.org/10.1182/blood.V120.21.3128.3128

Published: 2012

Journal Articles

Results From a Phase 1 Multicenter Trial of Alisertib (MLN8237)–An Investigational Aurora A Kinase Inhibitor–in Patients with Advanced Hematologic Malignancies

Kevin R. Kelly, MD, Swaminathan Padmanabhan, MBBS, MD, André Goy, MD, Jesus G. Berdeja, MD, Craig B. Reeder, MD, Kevin T. McDonagh, MD, Xiaofei Zhou, PhD, Hadi Danaee, SD, Hugh Xiao, PhD, Ely Benaim, MD, Thomas C. Shea, MD

Blood (2011) 118 (21): 2477.

https://doi.org/10.1182/blood.V118.21.2477.2477

Published: 2011

Journal Articles

Descriptive Study: sleep disorders breathing and Polysomnographic changes in Children and Adolescents with Sickle Cell Disease

Celia M. Campanaro, MD, Jose Carlos Pereira, Jr., MD, Jose Hugo Lins Pessoa, MD, Marcia Pradella Halimann, MD, Monica Favoreto, MD

Blood (2011) 118 (21): 4849.

https://doi.org/10.1182/blood.V118.21.4849.4849

Published: 2011

Journal Articles

Disturbance of B-Cell Homeostasis In Chronic Graft-Versus-Host Disease of the Lung

Zoya Kuzmina, Roman Weigl, Katharina Krenn, Ventzislav Petkov, Ulrike Koermoeczi, Arno Rottal, Christoph Zielinski, Hildegard T. Greinix, MD, Winfried Pickl

Blood (2010) 116 (21): 900.

https://doi.org/10.1182/blood.V116.21.900.900

Published: 2010

Journal Articles

Bronchiolitis Obliterans After Allogeneic Stem Cell Transplantation: a Single Center Retrospective Study of Risk Factors.

Hend Ben Neji, Claire Dromer, Reza Tabrizi, Stephane Vigouroux, Herve Guenard, Arnaud Pigneux, Thibaut Leguay, Marie-Sarah Dilhuydy, Krimo Bouabdallah, Anna Schmitt, Gerald Marit, Noel Milpied

Blood (2010) 116 (21): 4507.

https://doi.org/10.1182/blood.V116.21.4507.4507

Published: 2010

Journal Articles

Phase I Study of An Investigational Aurora A Kinase Inhibitor MLN8237 In Patients with Advanced Hematologic Malignancies.

Swaminathan Padmanabhan, MBBS, MD, Thomas C. Shea, MD, Julie M. Vose, MD, Craig B. Reeder, MD, Jesus G Berdeja, MD, Kevin T. McDonagh, MD, Andre Goy, MD, Kevin R Kelly, MD, Xiaofei Zhou, PhD, Hua Liu, PhD, Howard Fingert, MD, Nathan Fowler, MD

Blood (2010) 116 (21): 2799.

https://doi.org/10.1182/blood.V116.21.2799.2799

Published: 2010

Journal Articles

Antithymocyte Globuline Given as Part of the Conditioning Regimen Has No Impact On Lung Function at 1 Year After Transplantation.

Filippo Milano, MD, PhD, Margaret A. Au, H. J. Deeg, Jason Chien, MD

Blood (2009) 114 (22): 3306.

https://doi.org/10.1182/blood.V114.22.3306.3306

Published: 2009

Journal Articles

Successful High-Dose Ribavirin Treatment of Respiratory Syncytial Virus-Induced Tracheobronchitis and Pneumonia Occuring Pre-Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Saskia Gueller, MD, Ulrich Duenzinger, MD, Timo Wolf, MD, Sabine Mousset, MD, Hans Martin, MD, Hubert Serve, MD, Gesine Bug, MD

Blood (2009) 114 (22): 1163.

https://doi.org/10.1182/blood.V114.22.1163.1163

Published: 2009

Journal Articles

Submyeloablative Cord Blood Transplant Corrects Clinical Defects Seen in IPEX Syndrome.

Kenneth G. Lucas, MD, Melanie A. Comito, MD, David R. Ungar, MD, Brandt P. Groh, MD

Blood (2006) 108 (11): 5414.

https://doi.org/10.1182/blood.V108.11.5414.5414

Published: 2006

NARROW

Economic Burden of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in Patients with Commercial Insurance in the United States

Prevalence of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in the USA, Europe and Japan

Ruxolitinib and Steroid Refractory/Dependent Bronchiolitis Obliterans after Hematopoietic Cell Transplantation: A Steroid Sparing Agent That Also Resulted in Improved Lung Function in Children

Successful Salvage of Refractory Burkitts Lymphoma Using Maximum Intensity of the DA EPOCH-R Regimen—a Case Report

Pre-Transplant Pulmonary Function Test Parameters of FEF50% (Forced expiratory flow at 50% of forced vital capacity) and RV (residual volume) in Combination Can Predict the Risk for Development of Lung Gvhd after Allogeneic Transplantation

Comparison of Impulse Oscillometry with Spirometry to Assess Lung Function in Children with Sickle Cell Disease (SCD)

How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation

Adoptively-Transferred EBV-Specific T Cells to Prevent or Treat EBV-Related Lymphoproliferative Disease in Allogeneic HSCT Recipients - a Single Center Experience Spanning 22 Years

Clinical Features, Outcomes and Prognosis of Oropharyngeal Lymphoma: An Analysis from the Thai Lymphoma Study Group (TLSG)

The V50/V25 Ratio, a Marker of Small Airway Disease, Is Highly Predictive of Survival after Allogeneic Hematopoietic Cell Transplantation

Screening With Spirometry Is A Useful Predictor Of Later Development Of Non-Infectious Pulmonary Syndromes In Patients Undergoing Allogeneic Stem Cell Transplantation

Low Dose Busulfan Is Associated with Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation.

Results From a Phase 1 Multicenter Trial of Alisertib (MLN8237)–An Investigational Aurora A Kinase Inhibitor–in Patients with Advanced Hematologic Malignancies

Descriptive Study: sleep disorders breathing and Polysomnographic changes in Children and Adolescents with Sickle Cell Disease

Disturbance of B-Cell Homeostasis In Chronic Graft-Versus-Host Disease of the Lung

Bronchiolitis Obliterans After Allogeneic Stem Cell Transplantation: a Single Center Retrospective Study of Risk Factors.

Phase I Study of An Investigational Aurora A Kinase Inhibitor MLN8237 In Patients with Advanced Hematologic Malignancies.

Antithymocyte Globuline Given as Part of the Conditioning Regimen Has No Impact On Lung Function at 1 Year After Transplantation.

Successful High-Dose Ribavirin Treatment of Respiratory Syncytial Virus-Induced Tracheobronchitis and Pneumonia Occuring Pre-Engraftment in Allogeneic Hematopoietic Stem Cell Transplant Recipients.

Submyeloablative Cord Blood Transplant Corrects Clinical Defects Seen in IPEX Syndrome.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only